Radioimmunoassay of human beta interferon

Area of Science:

• Immunology
• Biochemistry
• Virology

Background:

• Interferons are crucial signaling proteins involved in immune responses.
• Accurate quantification of specific interferon types, like beta interferon, is essential for research and clinical diagnostics.
• Existing methods for interferon detection may lack sensitivity, specificity, or simplicity.

Purpose of the Study:

• To develop a sensitive and specific solid-phase radioimmunoassay (RIA) for human fibroblast-derived beta interferon.
• To establish a reproducible assay with a defined sensitivity limit.
• To assess the cross-reactivity of the assay with other interferon types and species.

Main Methods:

• A solid-phase RIA was developed using dinitrophenylated (DNP) IgG from rabbit anti-interferon serum.
• Antigen-bound antibodies were quantified by measuring the attachment of 125I-labeled anti-DNP.
• Sensitivity was determined using known concentrations of beta interferon.
• Cross-reactivity was tested with alpha interferon and mouse interferons.

Main Results:

• The assay demonstrated a sensitivity limit of 50 units of interferon, equivalent to 0.5 ng of interferon protein.
• Alpha leukocyte-derived interferon showed marginal cross-reactivity (<0.01%).
• Mouse interferons (alpha and beta mixture) were negative in the assay.
• The assay is simple and reproducible.

Conclusions:

• The developed RIA is a sensitive and specific method for quantifying human beta interferon.
• The use of 125I-labeled anti-DNP as a universal reagent offers potential for broader application in interferon testing.
• This assay could facilitate the development of RIA tests for interferons in both research and clinical settings.